Interpretation of Opiate Urine Drug Screens

The Guidance for Industry on Safety Testing of Drug Metabolites published by the US Food and Drug Administration in 2008 (and recently revised in 2016), as well as the ICH M3(R2) guidance, collectively provide recommenda-tions on how and when to characterize the nonclinical safety of drug metabolites of so-called small molecule (i.e. MW ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download